Thilo Zander
Impact in
-
- Multiple Myeloma Research and Treatments
-
- Glioma Diagnosis and Treatment
Papers in
- Oncology 12
- Peptidase Inhibition and Analysis 4
- Cancer Treatment and Pharmacology 2
- Hematology 12
- Multiple Myeloma Research and Treatments 10
- Co-authors
- Stefan Aebi (5 shared papers)Oliver Gautschi (3 shared papers)Joachim Diebold (2 shared papers)Astrid Hirschmann (1 shared paper)Klaus Strobel (1 shared paper)Thomas Pabst (12 shared papers)S. Wiedenmann (1 shared paper)Juergen Wolf (2 shared papers)
- Journals
- Swiss Medical Weekly (3 papers)Blood (2 papers)Journal of Thoracic Oncology (2 papers)Leukemia (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- SwitzerlandGermanyAustria
In The Last Decade
Thilo Zander
23 papers receiving 301 citations
Peers
Comparison fields: 5 of 45
- Hematology 61
- Genetics 58
- Oncology 143
- Pathology and Forensic Medicine 70
- Cancer Research 56
Countries citing papers authored by Thilo Zander
This map shows the geographic impact of Thilo Zander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thilo Zander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thilo Zander more than expected).
Fields of papers citing papers by Thilo Zander
This network shows the impact of papers produced by Thilo Zander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thilo Zander. The network helps show where Thilo Zander may publish in the future.
Co-authors
The 25 scholars most cited alongside Thilo Zander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 72 | |
| 2 | 2011 | 36 | |
| 3 | 2016 | 35 | |
| 4 | 2016 | 25 | |
| 5 | 2002 | 24 | |
| 6 | 2015 | 14 | |
| 7 | 2018 | 13 | |
| 8 | 2016 | 13 | |
| 9 | 2018 | 10 | |
| 10 | 2016 | 9 | |
| 11 | 2022 | 9 | |
| 12 | 2007 | 7 | |
| 13 | 2022 | 6 | |
| 14 | 2014 | 6 | |
| 15 | 2017 | 5 | |
| 16 | 2012 | 5 | |
| 17 | 2022 | 4 | |
| 18 | 2015 | 4 | |
| 19 | 2019 | 4 | |
| 20 | 2008 | 4 |
About Thilo Zander
Thilo Zander is a scholar working on Oncology, Hematology, Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 308 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (10 papers), Protein Degradation and Inhibitors (7 papers), Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (4 papers), Peptidase Inhibition and Analysis (4 papers), Lung Cancer Treatments and Mutations (3 papers), Cancer Treatment and Pharmacology (2 papers) and Medical Imaging Techniques and Applications (2 papers). The work is most often cited by research in Hematology (61 citations), Genetics (58 citations), Oncology (143 citations), Pathology and Forensic Medicine (70 citations) and Cancer Research (56 citations). Thilo Zander has collaborated with scholars based in Switzerland, Germany and Austria. Frequent co-authors include Stefan Aebi, Oliver Gautschi, Joachim Diebold, Astrid Hirschmann, Klaus Strobel, Thomas Pabst, S. Wiedenmann, Juergen Wolf, Daniel Betticher and Urban Novak. Their work appears in journals such as Swiss Medical Weekly, Blood, Journal of Thoracic Oncology, Leukemia and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.